Avidity Biosciences, Inc. announced the appointment of Steve Hughes, M.D. as chief medical officer. Dr. Hughes has over 20 years of experience building and leading clinical development and medical affairs teams at prominent biopharmaceutical companies. Dr. Hughes joins Avidity from Arcturus Therapeutics where he continues to be a strategic clinical advisor.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.36 USD | -4.25% | -1.22% | +213.48% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+213.48% | 2.83B | |
-1.62% | 89.22B | |
+1.32% | 40.49B | |
-15.51% | 32.79B | |
+64.13% | 26.23B | |
-22.04% | 14.52B | |
-7.58% | 13.09B | |
-44.07% | 11.6B | |
-13.06% | 11.5B | |
+4.94% | 8.82B |
- Stock Market
- Equities
- RNA Stock
- News Avidity Biosciences, Inc.
- Avidity Biosciences, Inc. Appoints Steve Hughes, M.D., as Chief Medical Officer